Craft

Progyny

Stock Price

$15.6

2024-10-29

Market Capitalization

$1.4 B

2024-10-29

Revenue

$1.3 B

FY, 2025

Progyny Summary

Company Summary

Overview
Progyny (formerly known as Auxogyn) is a company that specializes in fertility insurance and benefits. It offers benefits plan design, clinical and concierge support, surrogacy and adoption reimbursement, and other services. The company also provides Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment.
Type
Public
Status
Active
Founded
2008
HQ
New York, NY, US | view all locations
Website
https://progyny.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Peter Anevski

    Peter Anevski, Chief Executive Officer and Director

  • Risa Fisher

    Risa Fisher, EVP, Chief Marketing Officer

  • Mark Livingston, Chief Financial Officer

  • Michael Sturmer

Operating MetricsView all

Clients

392
39.0%

Q3, 2023

Industries

40
33.3%

Q3, 2023

Members

5.5M
19.6%

Q3, 2023

LocationsView all

1 location detected

  • New York, NY HQ

    United States

    1359 Broadway 2nd Floor

Progyny Financials

Summary Financials

Revenue (Q1, 2026)
$328.5M
Gross profit (Q1, 2026)
$83.1M
Net income (Q1, 2026)
$24.2M
Cash (Q1, 2026)
$131.6M
EBIT (Q1, 2026)
$35.4M
Enterprise value
$1.3B

Footer menu